Can One Aging Organ Accelerate Another?
Organs exchange metabolites, hormones, immune cells and circulating proteins, allowing dysfunction in one system to influence another. This essay explores cross-organ propagation of age-associated constraints while emphasizing common-cause confounding. It asks whether organ-specific functional trajectories can identify causal relationships rather than simply correlate multiple manifestations of illness.
Aging can travel between organs
Organs exchange hormones, metabolites, immune cells, proteins and extracellular vesicles. A kidney with reduced clearance alters the chemistry encountered by brain and heart; inflamed adipose tissue can influence vascular biology; altered marrow clones may send inflammatory cells throughout the body. Organ-specific proteomic aging estimates suggest that different systems can diverge, yet circulating signals allow those differences to influence neighboring physiology. The important question is which cross-organ communications are causal rather than merely correlated.
A proposed propagation model
An aging organ could increase another organ's vulnerability by increasing circulating harmful signals, reducing protective outputs or imposing higher metabolic demands. The receiving tissue's response would depend on its own reserve and local context. This model has experimental analogues in blood-exchange studies, although such experiments cannot isolate every factor nor establish simple clinical therapies. It differs from the idea that one bad organ always causes a cascade: chronic disease often has common upstream exposures affecting several organs simultaneously.
Why directionality matters
Suppose inflammatory proteins correlate with heart and kidney decline. Did the kidney cause the heart's deterioration, did vascular disease injure both, or did a third process change protein clearance and tissue function simultaneously? Cross-sectional measures cannot reliably decide. Longitudinal organ-specific measurements and mechanistic intervention studies are needed. The interpretation is especially difficult when plasma-proteomic scores are influenced by renal filtration and circulating cell populations.
A clinically useful consequence
The Institute's proposed concept of cross-organ regenerative constraint asks clinicians to identify whether a seemingly local treatment is limited by another organ. An orthopedic recovery plan may fail when severe anemia or heart failure reduces exercise tolerance. The idea becomes credible through precise examples, not through claiming all aging is transmitted through the blood.
A clinical thought experiment
If impaired kidney clearance elevates circulating proteins attributed to brain aging, a statistical organ-age model could appear to detect neurological decline when the primary change is filtration. Conversely, chronic marrow inflammation could genuinely affect vascular aging far from the blood-cell source. These scenarios require different explanations despite involving the same plasma compartment.
What would discriminate among explanations
Directionality can be investigated through repeated organ-specific measures, genetics, interventions and carefully chosen natural experiments. The general hypothesis fails if organ-specific effects dissolve after common causes are accounted for. Its value is as an invitation to map exchanges rather than assume that a blood biomarker identifies where the disorder began.
Selected scientific readings
- Oh HSH et al. (2025). Plasma proteomics links brain and immune system aging with healthspan and longevity. Nature Medicine. https://www.nature.com/articles/s41591-025-03798-1
- Jaiswal S et al. (2017). Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa1701719
- Heterochronic parabiosis for the study of the effects of aging on stem cells and their niches. Review (2012). https://pmc.ncbi.nlm.nih.gov/articles/PMC3383588/